glutamic acid has been researched along with grn-529 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andree, TH; Bender, CN; Brennan, J; Dunlop, J; Dwyer, JM; Harrison, JE; Hughes, ZA; Kouranova, E; Leonard, SK; Lotarski, S; Lu, S; Neal, SJ; O'Neil, SV; Olsen, M; Pulicicchio, CM; Ring, RH; Rosenzweig-Lipson, S; Schechter, LE; Smith, DL; Springer, D; Sukoff Rizzo, SJ; Whiteside, GT | 1 |
1 other study(ies) available for glutamic acid and grn-529
Article | Year |
---|---|
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Topics: Allosteric Regulation; Analgesics; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Benzamides; Calcium; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Glutamic Acid; HEK293 Cells; Humans; Mice; Pyridines; Radioligand Assay; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2013 |